GO
Loading...

Europe Video

European market closes mixed     Mon, 19 May '14 | 11:30 AM ET

European closed mixed on Monday, with traders shunning riskier assets amid concerns over stock valuations, policy action from the European Central Bank and upcoming elections in the region.

Execution risk and the disruptive element of Pfizer's offer on AstraZeneca's pipeline were also taken into consideration before rebuffing the U.S. giant, Leif Johansson, chairman at AstraZeneca, tells CNBC.

Leif Johansson, AstraZeneca's chairman, says the group engaged with shareholders before rejecting Pfizer's offer and included their price conditions for a deal after "very strong feedback" from shareholders.

Upside for Indian stocks?     Mon, 19 May '14 | 2:00 AM ET

Alan Higgins, U.K. CIO at Coutts, says Indian equities are expensive, but there could be potential upside if the new government implements the right reform.

Solar: Will it power the planet?     Wed, 14 May '14 | 7:00 PM ET

New advances in solar energy may transform the way we power our homes. CNBC explains.

Ben Lichtenstein, president of TradersAudio.com, says that a "major divergence" is developing in the U.S. market as the Russell and Nasdaq are "unwilling" to participate in the rally.

Gemma Godfrey, head of investment strategy at Brooks MacDonald, discusses the momentum stocks sell-off and the rotation from small caps into large caps.

Chuka Umunna, U.K. shadow secretary of State for business, innovation and skills, says that, in some cases, governments should intervene to protect domestic companies from foreign takeovers.

ECB rate cut will push euro lower: Pro     Mon, 19 May '14 | 5:20 AM ET

Boris Schlossberg, managing director at BK Asset Management, says the German flash PMI data out this week will be "absolutely critical" as a poor figure would escalate chances of ECB action.

Anshu Jain, co-CEO at Deutsche Bank, says the bank is very "focused" on its U.S. strategy and that it has a targeted plan to narrow the "competitive gap" there.

Deutsche Bank is taking steps to increase its capital reserves to take advantage of the "tectonic plate shift in European banking", Anshu Jain, co-CEO at Deutsche Bank told CNBC.

While AstraZeneca's management has rejected Pfizer's latest offer, there is still "some wriggle room." However, six months are needed before another offer can be brought forward, CNBC's Catherine Boyle reports.

Ryanair: Expect 'very good summer'     Mon, 19 May '14 | 4:40 AM ET

Stephen Furlong, senior transport analyst at Davy research, discusses why Ryanair's stock rose on Monday morning despite the group posting its first profit drop in five years.

Savvas Neophytou, pharmaceutical analyst at Panmure Gordon, says the probability of any further move from Pfizer on AstraZeneca has been greatly reduced as both groups disagree on the value of AstraZeneca's pipeline.

Malek Bou-Diab, portfolio manager at Bellevue African Opportunities, says structural reforms being carried out by African countries present opportunities for investing in the region, despite some of the political and security tensions that remain.

Bruce Stokes, director of the global economic program at the Pew Research Center, says support for the European Union is "rebounding" but in some countries it remains low.

Antonio Barroso, senior vice president at Teneo Intelligence, says the Portuguese government will not backtrack on its tough austerity reforms, but will need to offer voters incentives ahead of the election.

India: Market has room to move further     Mon, 19 May '14 | 4:30 AM ET

Maarten-Jan Bakkum, global emerging markets strategist at ING Investment Management, says a lot has already been priced into Indian assets but that the market still "has room to move."

Mick Cooper, health care analyst at Edison Investment Research, says that AstraZeneca is under a lot of pressure to deliver after it rejected Pfizer - which could come back in another six months.

Olivia Price-Walker, senior consultant at Frost and Sullivan, says the Internet of Things is at a "tipping point", while the large-scale use of 3D printing could have a big impact on manufacturers.

Matt Beesley, head of global equities at Henderson Global Investors, says developed market dividends are outpacing those in the emerging markets and are more sustainable.

Navid Malik, head of life sciences research at Cenkos Securities, says Pfizer won't return with another offer to buy AstraZeneca after its final bid was rejected.

Kerry Craig, global market strategist at JPMorgan Asset Management, says earnings growth in Europe is needed or there could be a pull back from equities in the region.

Ben Rogoff, fund manager at Polar Capital Partners, discusses the reports that Facebook is working on a video app to challenge Snapchat and why it makes sense for the company.

European shares opened slightly lower on Monday with traders still cautious on stock valuations and mulling over the possibility that the European Central Bank could look to stimulate the struggling euro zone economy.

AstraZeneca rejects Pfizer's final bid     Mon, 19 May '14 | 2:30 AM ET

AstraZeneca rejected Pfizer's final takeover offer on Monday saying the deal would bring "uncertainty and risks" to shareholders, CNBC's Catherine Boyle reports.

CNBC's Stephane Pedrazzi discusses reports that Siemens is preparing a formal bid for Alstom's power business that could come as early as this week.

James Steel, chief precious metals analyst at HSBC, discusses how inflation and commodity indices affects the price of oil and the knock on impact on gold.

UK housing market overheating?     Mon, 19 May '14 | 1:45 AM ET

John Wraith, head of U.K. rates strategy at Bank of America Merrill Lynch, discusses whether there is a bubble in the U.K. housing market and if this could affect the Bank of England's decision to raise interest rates.

Howard Millar, CFO of Ryanair, says the company is not planning to expand into long-haul flights as there is still a "huge opportunity" in short-haul flights.

Contact Europe Video

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More